Cinctive Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-50,000
Closed -$4.56M 557
2022
Q2
$4.56M Hold
50,000
0.19% 176
2022
Q1
$4.1M Buy
+50,000
New +$3.94M 0.15% 222
2021
Q4
Sell
-200,000
Closed -$15M 611
2021
Q3
$15M Buy
+200,000
New +$15.2M 0.74% 16

Other funds holding MRK

Cinctive Capital Management's MRK Position: Q2 2026 in Review

Cinctive Capital Management increased its Merck (MRK) stake by 801% in Q2 2026, buying an estimated $15.7M and bringing the position to 150,456 shares worth $19.3M. The position accounts for 0.71% of the portfolio, ranked #25.

Cinctive Capital Management first reported a position in MRK in Q3 2021 and has held it in 9 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Cinctive Capital Management held 150,456 shares of Merck worth $19.3M as of Q2 2026.
  • Cinctive Capital Management bought 133,749 Merck shares in Q2 2026, an estimated $15.7M.
  • Merck made up 0.71% of Cinctive Capital Management's portfolio in Q2 2026, its #25 holding.
  • Cinctive Capital Management first reported a position in Merck in Q3 2021 and has held it in 9 quarters since.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Cinctive Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.